Mediwound(MDWD)
$13.68+0.13 (+0.96%)
MDWD
Mediwound financials statements
$13.68
At close:+0.13 (+0.96%)
Want to see MDWD full AI Analyst Report?
Mediwound (MDWD) Ratios
467 Followers
Mediwound Ratios
MDWD's free cash flow for Q3 2026 was $-8.46M. For the 2026 fiscal year, MDWD's free cash flow was decreased by $-805.00K and operating cash flow was $-7.65M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.33 | 1.97 | 4.59 | 3.80 | 1.39 |
| Quick Ratio | 2.17 | 1.86 | 4.33 | 3.64 | 1.28 |
| Cash Ratio | 0.19 | 0.34 | 1.10 | 2.81 | 1.03 |
| Solvency Ratio | -0.52 | -0.68 | -0.16 | -0.47 | -0.51 |
| Operating Cash Flow Ratio | -0.57 | -0.51 | -0.97 | -0.99 | -0.83 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -32.59 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 17.34M | $ 9.82M | $ 14.83M | $ 6.74M | $ -9.37M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.09 | 0.10 | 0.02 | 0.07 |
| Debt-to-Equity Ratio | 0.19 | 0.22 | 0.20 | 0.08 | -0.30 |
| Debt-to-Capital Ratio | 0.16 | 0.18 | 0.17 | 0.07 | -0.44 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.98 | 2.36 | 2.10 | 4.58 | -4.31 |
| Debt Service Coverage Ratio | -32.64 | -28.59 | -15.16 | -112.14 | -72.73 |
| Interest Coverage Ratio | -38.13 | -34.55 | -46.27 | -47.29 | -67.19 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.77 | 0.75 | 0.74 | 0.20 | 0.40 |
| Net Debt to EBITDA | -0.16 | 0.08 | 1.13 | 1.83 | 0.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.19% | 13.03% | 15.77% | 46.50% | 34.24% |
| EBIT Margin | -137.57% | -145.44% | -33.16% | -73.06% | -56.21% |
| EBITDA Margin | -126.60% | -138.11% | -26.19% | -68.27% | -51.00% |
| Operating Profit Margin | -149.06% | -95.85% | -82.96% | -28.91% | -47.22% |
| Pretax Profit Margin | -139.81% | -149.16% | -34.95% | -73.68% | -56.91% |
| Net Profit Margin | -140.80% | -149.46% | -35.94% | -73.97% | -57.03% |
| Continuous Operations Profit Margin | -140.80% | -149.46% | -35.94% | -73.97% | -57.03% |
| Net Income Per EBT | 100.71% | 100.20% | 102.83% | 100.40% | 100.20% |
| EBT Per EBIT | 93.79% | 155.62% | 42.13% | 254.81% | 120.52% |
| Return on Assets (ROA) | -27.68% | -41.12% | -10.11% | -39.19% | -68.63% |
| Return on Equity (ROE) | -54.73% | -97.02% | -21.26% | -179.58% | 295.74% |
| Return on Capital Employed (ROCE) | -41.75% | -41.28% | -27.86% | -20.18% | -124.36% |
| Return on Invested Capital (ROIC) | -41.75% | -40.91% | -27.86% | -20.18% | -124.36% |
| Return on Tangible Assets | -27.69% | -41.18% | -10.13% | -39.37% | -69.68% |
| Earnings Yield | -11.37% | -17.05% | -7.33% | -29.13% | -21.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.15 | 3.46 | 4.23 | 2.73 | 10.48 |
| Payables Turnover | 3.80 | 4.29 | 3.73 | 2.51 | 3.33 |
| Inventory Turnover | 3.35 | 6.53 | 5.53 | 7.22 | 13.02 |
| Fixed Asset Turnover | 0.66 | 0.97 | 1.17 | 7.40 | 5.90 |
| Asset Turnover | 0.20 | 0.28 | 0.28 | 0.53 | 1.20 |
| Working Capital Turnover Ratio | 0.57 | 0.63 | 0.51 | 1.39 | 2.14 |
| Cash Conversion Cycle | 63.99 | 76.49 | 54.38 | 38.47 | -46.76 |
| Days of Sales Outstanding | 51.05 | 105.63 | 86.32 | 133.56 | 34.82 |
| Days of Inventory Outstanding | 109.01 | 55.87 | 66.00 | 50.54 | 28.03 |
| Days of Payables Outstanding | 96.06 | 85.00 | 97.93 | 145.63 | 109.61 |
| Operating Cycle | 160.06 | 161.49 | 152.32 | 184.10 | 62.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.28 | -1.37 | -1.16 | -2.38 | -2.29 |
| Free Cash Flow Per Share | -1.76 | -2.00 | -1.88 | -2.49 | -2.42 |
| Dividend Paid and CapEx Coverage Ratio | -2.64 | -2.17 | -1.62 | -21.41 | -18.23 |
| Capital Expenditure Coverage Ratio | -2.64 | -2.17 | -1.62 | -21.41 | -18.23 |
| Operating Cash Flow Coverage Ratio | -1.78 | -1.97 | -1.65 | -14.05 | -6.41 |
| Operating Cash Flow to Sales Ratio | -0.86 | -0.67 | -0.56 | -0.45 | -0.38 |
| Free Cash Flow Yield | -9.54% | -11.22% | -18.47% | -18.49% | -14.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.79 | -5.87 | -13.65 | -3.43 | -4.74 |
| Price-to-Sales (P/S) Ratio | 12.38 | 8.77 | 4.91 | 2.54 | 2.71 |
| Price-to-Book (P/B) Ratio | 4.81 | 5.69 | 2.90 | 6.16 | -14.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.48 | -8.91 | -5.41 | -5.41 | -6.84 |
| Price-to-Operating Cash Flow Ratio | -14.45 | -13.01 | -8.76 | -5.66 | -7.21 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | -0.02 | 0.17 | -0.27 | -0.10 |
| Enterprise Value Multiple | -9.94 | -6.27 | -17.61 | -1.89 | -4.51 |
| Enterprise Value | 213.36M | 175.06M | 86.15M | 34.23M | 54.64M |
| EV to EBITDA | -9.94 | -6.27 | -17.61 | -1.89 | -4.51 |
| EV to Sales | 12.58 | 8.66 | 4.61 | 1.29 | 2.30 |
| EV to Free Cash Flow | -10.65 | -8.80 | -5.09 | -2.75 | -5.81 |
| EV to Operating Cash Flow | -14.68 | -12.85 | -8.23 | -2.88 | -6.13 |
| Tangible Book Value Per Share | 3.83 | 3.12 | 3.49 | 2.14 | -1.25 |
| Shareholders’ Equity Per Share | 3.84 | 3.13 | 3.51 | 2.19 | -1.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.03 | -0.00 | -0.00 |
| Revenue Per Share | 1.49 | 2.03 | 2.07 | 5.31 | 6.11 |
| Net Income Per Share | -2.10 | -3.03 | -0.75 | -3.93 | -3.48 |
| Tax Burden | 1.01 | 1.00 | 1.03 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.03 | 1.05 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.84 | 0.44 | 0.38 | 0.36 | 0.42 |
| SG&A to Revenue | 0.82 | 0.64 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.18 | 0.16 | 0.10 | 0.07 | 0.07 |
| Income Quality | 0.61 | 0.45 | 1.56 | 0.61 | 0.66 |
Currency in USD

